Literature DB >> 20883986

Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop.

William H Catherino1, Estella Parrott, James Segars.   

Abstract

The purpose of the National Institutes of Health conference Fibroid Research Workshop in September 2007 was to bring Eunice Kennedy Shriver National Institute of Child Health and Human Development-funded fibroid investigators together to discuss basic science and clinical research advances on uterine leiomyomata. General topics included advances in epidemiology, etiology, therapeutic approaches, and clinical trial challenges; suggestions for advancement of basic understanding, clinical intervention, clinical trials, and future directions were highlighted. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2011        PMID： 20883986      PMCID： PMC4152853          DOI： 10.1016/j.fertnstert.2010.08.049

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  27 in total

1.  Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.

Authors:  Ping Yin; Zhihong Lin; Scott Reierstad; Ju Wu; Hiroshi Ishikawa; Erica E Marsh; Joy Innes; Youhong Cheng; Kerry Pearson; John Sayler Coon; J Julie Kim; Debabrata Chakravarti; Serdar E Bulun
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

2.  Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.

Authors:  Memy H Hassan; Salama A Salama; Dong Zhang; Hossam M M Arafa; Farid M A Hamada; Hala Fouad; Cheryl C Walker; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2009-01-14       Impact factor: 7.329

3.  Recruitment and retention of women for clinical leiomyoma trials.

Authors:  Desireé McCarthy-Keith; Sahadat Nurudeen; Alicia Armstrong; Eric Levens; Lynnette K Nieman
Journal:  Contemp Clin Trials       Date:  2009-09-27       Impact factor: 2.226

4.  Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.

Authors:  John M Norian; Minnie Malik; Candace Y Parker; Doina Joseph; Phyllis C Leppert; James H Segars; William H Catherino
Journal:  Reprod Sci       Date:  2009-08-21       Impact factor: 3.060

5.  The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells.

Authors:  Meagan M Grudzien; Philip Steven Low; Peter C Manning; Melissa Arredondo; Robert J Belton; Romana A Nowak
Journal:  Fertil Steril       Date:  2009-01-09       Impact factor: 7.329

6.  Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.

Authors:  Doina S Joseph; Minnie Malik; Sahadat Nurudeen; William H Catherino
Journal:  Fertil Steril       Date:  2009-03-27       Impact factor: 7.329

7.  Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.

Authors:  Xia Luo; Ping Yin; Scott Reierstad; Hiroshi Ishikawa; Zhihong Lin; Mary Ellen Pavone; Hong Zhao; Erica E Marsh; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2009-10-06       Impact factor: 5.958

8.  Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells.

Authors:  Fernando S Mesquita; Summer N Dyer; Daniel A Heinrich; Serdar E Bulun; Erica E Marsh; Romana A Nowak
Journal:  Biol Reprod       Date:  2009-09-09       Impact factor: 4.285

9.  High aromatase expression in uterine leiomyoma tissues of African-American women.

Authors:  Hiroshi Ishikawa; Scott Reierstad; Masashi Demura; Alfred W Rademaker; Tadayuki Kasai; Masaki Inoue; Hirokazu Usui; Makio Shozu; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

10.  microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.

Authors:  Qun Pan; Xiaoping Luo; Nasser Chegini
Journal:  Mol Hum Reprod       Date:  2009-11-11       Impact factor: 4.025
View more
  25 in total

1.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

2.  Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cells.

Authors:  Patricia Garcia; Phyllissa Schmiedlin-Ren; Jason S Mathias; Huaijing Tang; Gregory M Christman; Ellen M Zimmermann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-03       Impact factor: 4.052

Review 3.  Recent Advances in Uterine Fibroid Etiology.

Authors:  Michelle M McWilliams; Vargheese M Chennathukuzhi
Journal:  Semin Reprod Med       Date:  2017-03-09       Impact factor: 1.303

4.  Air pollution and risk of uterine leiomyomata.

Authors:  Shruthi Mahalingaiah; Jaime E Hart; Francine Laden; Kathryn L Terry; Renée Boynton-Jarrett; Ann Aschengrau; Stacey A Missmer
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

5.  Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.

Authors:  Faezeh Koohestani; Wenan Qiang; Amy L MacNeill; Stacy A Druschitz; Vanida A Serna; Malavika Adur; Takeshi Kurita; Romana A Nowak
Journal:  Hum Reprod       Date:  2016-04-29       Impact factor: 6.918

6.  Treatment for Uterine Fibroids: Searching for Effective Drug Therapies.

Authors:  Darlene K Taylor; Phyllis C Leppert
Journal:  Drug Discov Today Ther Strateg       Date:  2012

Review 7.  Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?

Authors:  Md Soriful Islam; Most Mauluda Akhtar; Andrea Ciavattini; Stefano Raffaele Giannubilo; Olga Protic; Milijana Janjusevic; Antonio Domenico Procopio; James H Segars; Mario Castellucci; Pasquapina Ciarmela
Journal:  Mol Nutr Food Res       Date:  2014-06-30       Impact factor: 5.914

8.  Activation of protein kinase B by WNT4 as a regulator of uterine leiomyoma stem cell function.

Authors:  Shimeng Liu; Ping Yin; Ariel J Dotts; Stacy A Kujawa; John S Coon V; Jian-Jun Wei; Debabrata Chakravarti; Serdar E Bulun
Journal:  Fertil Steril       Date:  2020-09-04       Impact factor: 7.329

9.  Health Care Costs and Treatment Patterns Associated with Uterine Fibroids and Heavy Menstrual Bleeding: A Claims Analysis.

Authors:  Alice Wang; Siting Wang; Charlotte D Owens; Jamie B Vora; Michael P Diamond
Journal:  J Womens Health (Larchmt)       Date:  2021-09-30       Impact factor: 3.017

Review 10.  A review and guide to creating patient specific 3D printed anatomical models from MRI for benign gynecologic surgery.

Authors:  Teresa E Flaxman; Carly M Cooke; Olivier X Miguel; Adnan M Sheikh; Sukhbir S Singh
Journal:  3D Print Med       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.